ClinConnect ClinConnect Logo
Search / Trial NCT05738902

Adherence and Compliance to ERAS in Gynecological Surgery

Launched by AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA · Feb 13, 2023

Trial Information

Current as of November 09, 2025

Recruiting

Keywords

Eras; Gynecologic Cancer;

ClinConnect Summary

This clinical trial is investigating how following a specific care plan called Enhanced Recovery After Surgery (ERAS) affects recovery after gynecological surgeries, particularly for women with cancers like ovarian, endometrial, and cervical cancer. The study aims to understand if not sticking to this care plan in the first two days after surgery is linked to complications during recovery. Researchers are currently looking for women aged 18 to 75 who have been diagnosed with these types of cancers and who will undergo open surgery.

If you or a loved one is eligible and chooses to participate, you can expect to be part of a group that will help researchers learn more about how following this recovery plan can help improve surgical outcomes. Participants will be monitored for any complications that may arise after surgery. It’s important to know that certain factors, like needing intensive care after surgery or having a previous surgery, may disqualify someone from joining the study. This trial is currently recruiting, so there is an opportunity to contribute to important research aimed at improving post-surgery care for women with gynecological cancers.

Gender

FEMALE

Eligibility criteria

  • Inclusion criteria:
  • histological diagnosis of primary or recurrent gynecological cancer (endometrial, uterine, tubo-ovarian and cervical cancer);
  • perioperative management according to ERAS guidelines;
  • age 18-75;
  • open access surgery.
  • Exclusion criteria:
  • postoperative recovery in intensive care unit (planned or unplanned);
  • Covid19 positive status known at the moment of surgery;
  • minimally invasive access surgery or palliative surgery;
  • prior pelvic radiotherapy;
  • hyperthermic intraperitoneal chemotherapy;
  • previous abdominal surgery (excluding appendectomy and primary surgery for gynecological malignancy);
  • pelvic exenteration or lateral extended endopelvic resection (LEER).

About Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

The Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia is a leading healthcare organization based in Brescia, Italy, dedicated to providing high-quality medical services and promoting clinical research. As a prominent clinical trial sponsor, it focuses on advancing medical knowledge and improving patient care through innovative research initiatives. The institution integrates multidisciplinary expertise and state-of-the-art facilities to facilitate the development of new therapies and treatments, ensuring adherence to rigorous ethical and regulatory standards. With a commitment to enhancing public health, the Azienda plays a pivotal role in fostering collaborations among healthcare professionals, researchers, and industry partners.

Locations

Brescia, Bs, Italy

Patients applied

0 patients applied

Trial Officials

Federico Ferrari, MD, PhD

Principal Investigator

University of Brescia, Italy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials